Pluri (PLUR) Short-term Investments (2011 - 2025)
Pluri (PLUR) posted quarterly Short-term Investments of $224000.0 for Q4 2025, down 14.18% year-over-year from $261000.0 in Q4 2024, and down 47.66% quarter-over-quarter from $428000.0 in Q3 2025.
Pluri (PLUR) Short-term Investments (2011 - 2025) Analysis & Trends
Pluri (PLUR) has reported Short-term Investments for 15 consecutive years, with $224000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Short-term Investments fell 14.18% year-over-year to $224000.0; the TTM figure through Dec 2025 stood at $224000.0 (down 14.18% YoY), while the FY2025 annual figure was $14.7 million, down 36.57% from the prior year.
- Short-term Investments declined to $224000.0 in Q4 2025 per PLUR's latest filing, from $428000.0 in the prior quarter.
- Across five years, Short-term Investments topped out at $46.1 million in Q3 2021 and bottomed at $224000.0 in Q4 2025.
- Historically, Short-term Investments has averaged $15.7 million across 5 years, with a median of $488500.0 in 2021.
- Annual changes were most pronounced in 2022 — Short-term Investments jumped 7479.49% — and 2023, when it plunged 99.25%.
- Pluri's Short-term Investments stood at $507000.0 in 2021, then surged by 7479.49% to $38.4 million in 2022, then slumped by 99.03% to $373000.0 in 2023, then slumped by 30.03% to $261000.0 in 2024, then retreated by 14.18% to $224000.0 in 2025.
- Business Quant data shows PLUR's Short-term Investments at $224000.0 in Q4 2025, $428000.0 in Q3 2025, and $14.7 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Pluri | 16.21 Mn | 3.72 Mn | 86,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 224,000.00 |
| Sep 30, 2025 | 428,000.00 |
| Jun 30, 2025 | 14.72 Mn |
| Mar 31, 2025 | 407,000.00 |
| Dec 31, 2024 | 261,000.00 |
| Sep 30, 2024 | 365,000.00 |
| Jun 30, 2024 | 23.20 Mn |
| Mar 31, 2024 | 273,000.00 |
| Dec 31, 2023 | 373,000.00 |
| Sep 30, 2023 | 295,000.00 |
| Jun 30, 2023 | 34.81 Mn |
| Mar 31, 2023 | 273,000.00 |
| Dec 31, 2022 | 38.43 Mn |
| Sep 30, 2022 | 39.27 Mn |
| Jun 30, 2022 | 45.24 Mn |
| Mar 31, 2022 | 470,000.00 |
| Dec 31, 2021 | 507,000.00 |
| Sep 30, 2021 | 46.06 Mn |
| Jun 30, 2021 | 33.71 Mn |
| Mar 31, 2021 | 35.11 Mn |